Can Shanghai Menon Animal Nutrition Technology Co., Ltd.'s (SZSE:301156) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?

Shanghai Menon Animal Nutrition Technology (SZSE:301156) has had a great run on the share market with its stock up by a significant 15% over the last three months. However, we decided to pay close attention to its weak financials as we are doubtful that the current momentum will keep up, given the scenario. Specifically, we decided to study Shanghai Menon Animal Nutrition Technology's ROE in this article.

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.

Check out our latest analysis for Shanghai Menon Animal Nutrition Technology

How Do You Calculate Return On Equity?

ROE can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Shanghai Menon Animal Nutrition Technology is:

6.1% = CN¥45m ÷ CN¥740m (Based on the trailing twelve months to September 2024).

The 'return' refers to a company's earnings over the last year. So, this means that for every CN¥1 of its shareholder's investments, the company generates a profit of CN¥0.06.

What Has ROE Got To Do With Earnings Growth?

Thus far, we have learned that ROE measures how efficiently a company is generating its profits. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company’s earnings growth potential. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.

A Side By Side comparison of Shanghai Menon Animal Nutrition Technology's Earnings Growth And 6.1% ROE

When you first look at it, Shanghai Menon Animal Nutrition Technology's ROE doesn't look that attractive. Next, when compared to the average industry ROE of 7.6%, the company's ROE leaves us feeling even less enthusiastic. Therefore, Shanghai Menon Animal Nutrition Technology's flat earnings over the past five years can possibly be explained by the low ROE amongst other factors.

We then compared Shanghai Menon Animal Nutrition Technology's net income growth with the industry and found that the company's growth figure is lower than the average industry growth rate of 2.5% in the same 5-year period, which is a bit concerning.

Earnings growth is an important metric to consider when valuing a stock. It’s important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). Doing so will help them establish if the stock's future looks promising or ominous. If you're wondering about Shanghai Menon Animal Nutrition Technology's's valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.

Is Shanghai Menon Animal Nutrition Technology Making Efficient Use Of Its Profits?

The high three-year median payout ratio of 95% (meaning, the company retains only 4.5% of profits) for Shanghai Menon Animal Nutrition Technology suggests that the company's earnings growth was miniscule as a result of paying out a majority of its earnings.

Additionally, Shanghai Menon Animal Nutrition Technology started paying a dividend only recently. So it looks like the management must have perceived that shareholders favor dividends over earnings growth.

Conclusion

On the whole, Shanghai Menon Animal Nutrition Technology's performance is quite a big let-down. Specifically, it has shown quite an unsatisfactory performance as far as earnings growth is concerned, and a poor ROE and an equally poor rate of reinvestment seem to be the reason behind this inadequate performance. Up till now, we've only made a short study of the company's growth data. You can do your own research on Shanghai Menon Animal Nutrition Technology and see how it has performed in the past by looking at this FREE detailed graph of past earnings, revenue and cash flows.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.